Actipulse Neuroscience

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.

'neuromodulation; depression; alzheimer''s; and neurotech'

Actipulse neuroscience operates in the Mental health care industry.

Actipulse neuroscience's revenue is 11m - 100m

Actipulse neuroscience has 11 - 50 employees.